After five years, Nido Biosciences has reached the end of the road, closing its doors after its lead neurological disease candidate disappointed in a midstage study. Founded by 5AM Ventures’ 4:59 ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...

Welcome to Fierce Biotech's fifth annual layoff tracker, a resource designed to keep pace with the sector's steady stream of workforce reductions. In 2025, industry layoffs continued to rise year over ...

A decade ago, entrepreneur PC Zhu was in the United States, starting up a Boston-based outfit helping biotech startups grow. Today he is in Shanghai, building one of the country’s most ambitious ...

Some of the best-selling drugs in the world are facing a loss of exclusivity in key jurisdictions in the upcoming years in what the sector calls "the patent cliff." The need for pharma to top up their ...

The financial trajectory of the exosome therapy market is decoupling from the broader, slower-growing regenerative medicine ...

Eli Lilly LLY-2.12%decrease; red down pointing triangle is in advanced talks to acquire Ventyx Biosciences VTYX 0.79%increase; green up pointing triangle for around $1 billion, according to people ...

This whitepaper explores the role of process analytical technology (PAT) in enhancing the efficiency of upstream ...

HIGHLAND PARK Fla. — A Florida nonprofit is on a mission to revive the state’s farmland with sustainability in mind. Biotech Applied Research is turning waste into “biochar,” a charcoal-like material.

Jan 14 (Reuters) - Investors are eyeing a rebound in the U.S. biotech sector in 2026, as more companies are expected to go public amid a renewed deal-making appetite and a lower interest rate scenario ...

A run-up in biotech and drug stocks that sent valuations soaring through the second half of 2025 was looking a bit shaky on Monday, as investors poured cash into energy shares following the U.S.